Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Biospes manufactures and supplies high-quality life science reagents including antibodies, ELISA kits, proteins, apoptosis kits, biochemicals, and related products. Their products are widely used in academic research as well as pharmaceutical and disease studies. The company emphasizes innovation through its R&D team and strict quality control system. They offer both standard HRP-conjugated ELISA systems and biotin-conjugated antibody plus ABC systems to ensure high sensitivity/stability with low background in assays. Custom services are available for antibodies/ELISA kits/proteins to meet specific customer needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Biospes.